Smith & Nephew SNATS Inc (SNN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Smith & Nephew SNATS Inc (SNN) has a cash flow conversion efficiency ratio of 0.168x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($888.43 Million) by net assets ($5.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Smith & Nephew SNATS Inc (SNN) market capitalisation for the company's overall valuation and market capitalisation.
Smith & Nephew SNATS Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Smith & Nephew SNATS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Smith & Nephew SNATS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Smith & Nephew SNATS Inc ranked by their cash flow conversion efficiency. Explore earnings quality score of Smith & Nephew SNATS Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zydus Lifesciences Limited
NSE:ZYDUSLIFE
|
0.014x |
|
PRADA S.P.A.UNS.ADR/2 EO1
F:PRP0
|
N/A |
|
One 97 Communications Limited
NSE:PAYTM
|
0.003x |
|
Samsung Heavy Industries
KO:010140
|
0.334x |
|
Manhattan Associates Inc
NASDAQ:MANH
|
0.576x |
|
KERRY GRP PLC ADR/1EO-12
F:KRZA
|
N/A |
|
YTL Power International Bhd
KLSE:6742
|
0.069x |
|
CoStar Group Inc
NASDAQ:CSGP
|
0.014x |
Annual Cash Flow Conversion Efficiency for Smith & Nephew SNATS Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Smith & Nephew SNATS Inc from 1991 to 2025. View Smith & Nephew SNATS Inc (SNN) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.29 Billion | $1.29 Billion | 0.244x | +29.90% |
| 2024-12-31 | $5.26 Billion | $987.00 Million | 0.187x | +60.86% |
| 2023-12-31 | $5.22 Billion | $608.00 Million | 0.117x | +30.96% |
| 2022-12-31 | $5.26 Billion | $468.00 Million | 0.089x | -43.50% |
| 2021-12-31 | $5.57 Billion | $877.00 Million | 0.158x | -11.07% |
| 2020-12-31 | $5.28 Billion | $935.00 Million | 0.177x | -22.04% |
| 2019-12-31 | $5.14 Billion | $1.17 Billion | 0.227x | +18.94% |
| 2018-12-31 | $4.87 Billion | $931.00 Million | 0.191x | -18.62% |
| 2017-12-31 | $4.64 Billion | $1.09 Billion | 0.235x | +9.42% |
| 2016-12-31 | $3.96 Billion | $849.00 Million | 0.215x | -17.41% |
| 2015-12-31 | $3.97 Billion | $1.03 Billion | 0.260x | +53.62% |
| 2014-12-31 | $4.04 Billion | $683.00 Million | 0.169x | -21.09% |
| 2013-12-31 | $4.05 Billion | $867.00 Million | 0.214x | -7.75% |
| 2012-12-31 | $3.88 Billion | $902.00 Million | 0.232x | -12.10% |
| 2011-12-31 | $3.19 Billion | $842.00 Million | 0.264x | -14.71% |
| 2010-12-31 | $2.77 Billion | $859.00 Million | 0.310x | -6.12% |
| 2009-12-31 | $2.18 Billion | $719.00 Million | 0.330x | -0.95% |
| 2008-12-31 | $1.70 Billion | $566.00 Million | 0.333x | +42.68% |
| 2007-12-31 | $1.82 Billion | $424.00 Million | 0.233x | +44.20% |
| 2006-12-31 | $2.17 Billion | $352.00 Million | 0.162x | -10.64% |
| 2005-12-31 | $1.44 Billion | $260.00 Million | 0.181x | -32.84% |
| 2004-12-31 | $1.35 Billion | $363.28 Million | 0.270x | +11.54% |
| 2003-12-31 | $1.14 Billion | $276.79 Million | 0.242x | -17.01% |
| 2002-12-31 | $833.21 Million | $242.85 Million | 0.291x | +18.88% |
| 2001-12-31 | $589.18 Million | $144.46 Million | 0.245x | +120.17% |
| 2000-12-31 | $399.84 Million | $-486.02 Million | -1.216x | -1043.20% |
| 1999-12-31 | $892.49 Million | $115.02 Million | 0.129x | -11.38% |
| 1998-12-31 | $805.88 Million | $117.19 Million | 0.145x | -2.36% |
| 1997-12-31 | $762.58 Million | $113.57 Million | 0.149x | -21.88% |
| 1996-12-31 | $745.62 Million | $142.14 Million | 0.191x | +64.49% |
| 1995-12-31 | $625.35 Million | $72.47 Million | 0.116x | -31.01% |
| 1994-12-31 | $697.12 Million | $117.10 Million | 0.168x | +99.28% |
| 1993-12-31 | $514.17 Million | $43.34 Million | 0.084x | -39.18% |
| 1992-12-31 | $549.35 Million | $76.14 Million | 0.139x | -29.87% |
| 1991-12-31 | $538.71 Million | $106.47 Million | 0.198x | -- |
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more